TY - JOUR
T1 - Cerebral Autoregulation Monitoring in Traumatic Brain Injury
T2 - An Overview of Recent Advances in Personalized Medicine
AU - Zeiler, Frederick Adam
AU - Aries, Marcel
AU - Czosnyka, Marek
AU - Smieleweski, Peter
N1 - Funding Information:
This work was directly funded through the Manitoba Public Insurance (MPI) Professorship in Neuroscience and TBI Research Operating Fund, and the Health Sciences Centre Foundation Winnipeg, the Natural Sciences and Engineering Research Council of Canada (NSERC)(DGECR-2022-00260 and RGPIN-2022-03621).
Funding Information:
F.A.Z receives research support from the Manitoba Public Insurance (MPI) Professorship in Neuroscience and TBI Research Operating Fund, the Health Sciences Centre Foundation Winnipeg, the Canada Foundation for Innovation (CFI)(Project #: 38583), Research Manitoba (Grant #: 3906), the University of Manitoba VPRI Research Investment Fund (RIF), the Canadian Institutes of Health Research (CIHR)(Grant #: 472286), and the Natural Sciences and Engineering Research Council of Canada (NSERC).
Funding Information:
Funding Information This work was directly funded through theManitoba Public Insurance (MPI) Professorship in Neuroscience and TBI Research Operating Fund, and the Health Sciences Centre Foundation Winnipeg, the Natural Sciences and Engineering Research Council of Canada (NSERC)(DGECR-2022- 00260 and RGPIN-2022-03621).
Publisher Copyright:
© Copyright 2022, Mary Ann Liebert, Inc., publishers 2022.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Impaired cerebral autoregulation (CA) in moderate/severe traumatic brain injury (TBI) has been identified as a strong associate with poor long-term outcomes, with recent data highlighting its dominance over cerebral physiologic dysfunction seen in the acute phase post injury. With advances in bedside continuous cerebral physiologic signal processing, continuously derived metrics of CA capacity have been described over the past two decades, leading to improvements in cerebral physiologic insult detection and development of novel personalized approaches to TBI care in the intensive care unit (ICU). This narrative review focuses on highlighting the concept of continuous CA monitoring and consequences of impairment in moderate/severe TBI. Further, we provide a comprehensive description and overview of the main personalized cerebral physiologic targets, based on CA monitoring, that are emerging as strong associates with patient outcomes. CA-based personalized targets, such as optimal cerebral perfusion pressure (CPPopt), lower/upper limit of regulation (LLR/ULR), and individualized intra-cranial pressure (iICP) are positioned to change the way we care for TBI patients in the ICU, moving away from the "one treatment fits all" paradigm of current guideline-based therapeutic approaches, towards a true personalized medicine approach tailored to the individual patient. Future perspectives regarding research needs in this field are also discussed.
AB - Impaired cerebral autoregulation (CA) in moderate/severe traumatic brain injury (TBI) has been identified as a strong associate with poor long-term outcomes, with recent data highlighting its dominance over cerebral physiologic dysfunction seen in the acute phase post injury. With advances in bedside continuous cerebral physiologic signal processing, continuously derived metrics of CA capacity have been described over the past two decades, leading to improvements in cerebral physiologic insult detection and development of novel personalized approaches to TBI care in the intensive care unit (ICU). This narrative review focuses on highlighting the concept of continuous CA monitoring and consequences of impairment in moderate/severe TBI. Further, we provide a comprehensive description and overview of the main personalized cerebral physiologic targets, based on CA monitoring, that are emerging as strong associates with patient outcomes. CA-based personalized targets, such as optimal cerebral perfusion pressure (CPPopt), lower/upper limit of regulation (LLR/ULR), and individualized intra-cranial pressure (iICP) are positioned to change the way we care for TBI patients in the ICU, moving away from the "one treatment fits all" paradigm of current guideline-based therapeutic approaches, towards a true personalized medicine approach tailored to the individual patient. Future perspectives regarding research needs in this field are also discussed.
U2 - 10.1089/neu.2022.0217
DO - 10.1089/neu.2022.0217
M3 - (Systematic) Review article
C2 - 35793108
SN - 0897-7151
VL - 39
SP - 1477
EP - 1494
JO - Journal of Neurotrauma
JF - Journal of Neurotrauma
IS - 21-22
ER -